ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.62
-0.28%
US Tech 100
17,680.80
0.23%
S&P 500
5,216.50
0.05%
US Dollar vs CAD
1.36765
-0.01%
Bitcoin
60,550.00
-3.96%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE
  6. Aston Martin Np (AMLN)

  7. Aston Martin Np (AMLN) News

AMLN

Aston Martin Np (AMLN)

Aston Martin Np
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:AMLN
DateTimeSourceHeadlineSymbolCompany
09/26/202210:36AMUK RegulatoryAston Martin Lagonda Global - AMLN Price Monitoring ExtensionLSE:AMLNAston Martin Np
09/23/202210:41AMUK RegulatoryAston Martin Lagonda Global - AMLN Second Price Monitoring ExtnLSE:AMLNAston Martin Np
09/23/202210:36AMUK RegulatoryAston Martin Lagonda Global - AMLN Price Monitoring ExtensionLSE:AMLNAston Martin Np
09/22/202210:41AMUK RegulatoryAston Martin Lagonda Global - AMLN Second Price Monitoring ExtnLSE:AMLNAston Martin Np
09/22/202210:35AMUK RegulatoryAston Martin Lagonda Global - AMLN Price Monitoring ExtensionLSE:AMLNAston Martin Np
09/21/202210:40AMUK RegulatoryAston Martin Lagonda Global - AMLN Second Price Monitoring ExtnLSE:AMLNAston Martin Np
09/21/202210:35AMUK RegulatoryAston Martin Lagonda Global - AMLN Price Monitoring ExtensionLSE:AMLNAston Martin Np
09/15/202210:35AMUK RegulatoryAston Martin Lagonda Global - AMLN Price Monitoring ExtensionLSE:AMLNAston Martin Np
04/17/20208:01AMUK RegulatoryAston Martin Lagonda Global - AMLN Price Monitoring ExtensionLSE:AMLNAston Martin Np
04/15/202010:41AMUK RegulatoryAston Martin Lagonda Global - AMLN Second Price Monitoring ExtnLSE:AMLNAston Martin Np
04/15/202010:37AMUK RegulatoryAston Martin Lagonda Global - AMLN Price Monitoring ExtensionLSE:AMLNAston Martin Np
04/14/202010:41AMUK RegulatoryAston Martin Lagonda Global - AMLN Second Price Monitoring ExtnLSE:AMLNAston Martin Np
04/14/202010:37AMUK RegulatoryAston Martin Lagonda Global - AMLN Price Monitoring ExtensionLSE:AMLNAston Martin Np
04/07/202010:40AMUK RegulatoryAston Martin Lagonda Global - AMLN Second Price Monitoring ExtnLSE:AMLNAston Martin Np
04/07/202010:36AMUK RegulatoryAston Martin Lagonda Global - AMLN Price Monitoring ExtensionLSE:AMLNAston Martin Np
01/13/20108:31AMPR Newswire (US)Critical Alerts for Hartford Financial Services, Apple, Yamana Gold, Amylin Pharmaceuticals and MetLife Released by Seven SummitNASDAQ:AMLN
11/05/20093:15PMPR Newswire (US)Amylin Pharmaceuticals to Present at the 18th Annual Credit Suisse Healthcare ConferenceNASDAQ:AMLN
11/01/20095:30PMPR Newswire (US)Amylin Pharmaceuticals and Takeda Enter into Worldwide Agreement to Co-Develop and Commercialize Compounds for ObesityNASDAQ:AMLN
10/30/20097:16PMPR Newswire (US)BYETTA Approved for Expanded Use as First-Line Treatment for Type 2 DiabetesNASDAQ:AMLN
10/29/20097:34AMDow Jones NewsUPDATE: Roche's New Diabetes Drug Works Better Than ByettaNASDAQ:AMLNAmylin Pharmaceuticals Inc.
10/29/20094:02AMDow Jones NewsRoche: New Diabetes Drug Works Better Than Byetta - StudyNASDAQ:AMLNAmylin Pharmaceuticals Inc.
10/22/20097:00AMPR Newswire (US)Amylin Pharmaceuticals to Present at the 4th Annual BIOCOM Investor ConferenceNASDAQ:AMLN
10/19/20094:21PMDow Jones News2ND UPDATE:Galleon Holdings Include OSI Pharma,Huron ConsultingNASDAQ:AMLNAmylin Pharmaceuticals Inc.
10/19/20093:17PMDow Jones NewsUPDATE: Galleon Holdings Include OSI Pharma, Huron ConsultingNASDAQ:AMLNAmylin Pharmaceuticals Inc.
10/19/20093:05PMDow Jones NewsGalleon Holdings Include OSI Pharmaceuticals, Huron ConsultingNASDAQ:AMLNAmylin Pharmaceuticals Inc.
09/30/20095:16AMDow Jones NewsNovo Nordisk's Diabetes Drug Victoza Successful In StudyNASDAQ:AMLNAmylin Pharmaceuticals Inc.
08/24/20096:45AMPR Newswire (US)Amylin Pharmaceuticals Board of Directors Elects Paulo F. Costa Chairman of the BoardNASDAQ:AMLN
08/06/20097:28AMDow Jones NewsNovo Nordisk CEO: Positive Victoza Reception In EuropeNASDAQ:AMLNAmylin Pharmaceuticals Inc.
07/21/20094:20PMDow Jones NewsAmylin 2Q Loss Narrows On Cost-Cutting; Byetta Sales SlipNASDAQ:AMLNAmylin Pharmaceuticals Inc.
07/20/20093:14PMPR Newswire (US)Exenatide Once Weekly Provided Superior Glucose Control Compared to Lantus(R) in Head-to-Head DURATION-3 StudyNASDAQ:AMLN
 Showing the most relevant articles for your search:LSE:AMLN

Your Recent History

USOTC
EMGE
Emergent Health (PK)
NASDAQ
RNAZ
TransCode Therapeutics
USOTC
SONG
Music Licensing (PK)
USOTC
TXTM
ProText Mobility (PK)
USOTC
IQST
iQSTEL (QX)
USOTC
ASKH
Astika (PK)
USOTC
YCRM
Yuenglings Ice Cream (PK)
USOTC
VDRM
ViaDerma (PK)
USOTC
IBGR
Nexus Energy Services (PK)
USOTC
GSTC
Globestar Therapeutics (PK)
USOTC
IPIX
Innovation Pharmaceuticals (CE)
USOTC
NSAV
Net Savings Link (PK)
USOTC
SFLM
SFLMaven (PK)
USOTC
NLST
Netlist (QB)
USOTC
CNNA
Cann American (CE)
USOTC
TKMO
Tekumo (PK)
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved